Home' Australian Pharmacist : Australian Pharmacist July 2014 Contents Australian Pharmacist July 2014 I ©Pharmaceutical Society of Australia Ltd.
1. Kennedy BK, Pennypacker JK. Drugs that modulate aging: the
promising yet difficult path ahead. Translational research: the
journal of laborator y and clinical medicine 2014;163(5):456–65.
2. Bendjilali N, Hsueh WC, He Q, Willcox DC, Nievergelt CM,
Donlon TA, et al. Who are the Okinawans? Ancestry, genome
diversity, and implications for the genetic study of human
longevity from a geographically isolated population. The
journals of gerontology. Series A, Biological sciences and
medical sciences 2014.
3. Willcox BJ, Willcox DC, He Q, Curb JD, Suzuki M. Siblings of
Okinawan centenarians share lifelong mortality advantages. J
Gerontol A Biol Sci Med Sci 2006;61:345–54.
4. Willcox DC, Willcox BJ, Todoriki H, Curb JD, Suzuki M. Caloric
restriction and human longevity: what can we learn from the
Okinawans? Biogerontology 2006;7(3):173–7.
5. Willcox BJ, Yano K, Chen R, Willcox DC, Rodriguez BL, Masaki
KH, et al. How much should we eat? The association between
energy intake and mortality in a 36-year follow-up study
of Japanese-American men. J Gerontol A Biol Sci Med Sci
6. Masoro EJ. Caloric restriction and aging: an update. Exp
7. Tran C. Caloric restriction slows immune aging. Study finds that
calorie-restricted rhesus monkeys have a higher percentage
of naïve T cells. The Scientist (daily). 5 Dec 2006. At: www.the-
8. Baur JA, Ungvari Z, Minor RK, et al. Are sirtuins viable targets
for improving healthspan and lifespan? Nature reviews Drug
discover y 2012;11(6):443–61.
9. Agarwal B, Baur JA. Resveratrol and life extension. Annals of the
New York Academy of Sciences 2011;1215:138–43.
10. Guo YS. Recent anti-aging studies on caloric restriction and
resveratrol. Progress in physiology 2011;42(3):161–4.
11. Lam YY, Peterson CM, Ravussin E. Resveratrol vs. calorie
restriction: data from rodents to humans. Experimental
12. Marchal J, Pifferi F, Aujard F. Resveratrol in mammals: effects on
aging biomarkers, age-related diseases, and life span. Annals of
the New York Academy of Sciences 2013;1290:67–73.
13. de la Lastra CA, Villegas I. Resveratrol as an anti-inflammator y
and anti-aging agent: mechanisms and clinical implications.
Mol Nutr Food Res 2005;49:405–30.
14. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, K alra A, et
al. Resveratrol improves health and survival of mice on a high-
calorie diet. Nature 2006;444:337–42.
15. Valenzano DR, Cellerino A. Resveratrol and the pharmacology of
aging: a new vertebrate model to validate an old molecule. Cell
16. Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan
FA, Garcia-Conesa MT, Espin JC. Resveratrol and clinical trials:
the crossroad from in vitro studies to human evidence. Current
pharmaceutical design 2013;19(34):6064–93 .
17. Finkel T. Ageing: a toast to long life. Nature 2003;425:132–3.
18. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S,
Wood JG, et al. Small molecule activators of sirtuins extend
Saccharomyces cerevisiae lifespan. Nature 2003;425:191–6 .
19. Vang O, Ahmad N, Baile CA, et al. What is new for an old
molecule? Systematic review and recommendations on the
use of resveratrol. PloS One 2011;6(6):e19881.
20. Poulsen MM, Jorgensen JO, Jessen N, Richelsen B, Pedersen
SB. Resveratrol in metabolic health: an overview of the current
evidence and perspectives. Annals of the New York Academy
of Sciences 2013;1290:74–82.
21. Borriello A, Bencivenga D, Caldarelli I, Tramontano A, Borgia
A, Zappia V, et al. Resveratrol: from basic studies to bedside.
Cancer treatment and research 2014;159:167–84.
22. Jessen N, Richelsen B, Pedersen SB. Resveratrol in metabolic
health: an overview of the current evidence and perspectives.
Annals of the New York Academy of Sciences 2013;1290:74–82.
23. Semba RD, Ferrucci L, Bartali B, Urpi-Sarda M, Zamora-Ros R,
Sun K, et al. Resveratrol levels and all-cause mortality in older
community-dwelling adults. JAMA Intern Med 2014. Published
online May 12, 2014. doi:10.1001/jamainternmed.2014.1582
24. Turbill C, Ruf T, Smith S, Bieber C. Seasonal variation in telomere
length of a hibernating rodent. Biol Lett 2013;9(2):20121095.
25. Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher
KI, Luo J, et al. Young blood reverses age-related impairments
in cognitive function and synaptic plasticity in mice. Nat Med
2014. Published online May 4, 2014. doi: 10.1038/nm.3569
26. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Loffredo FS,
Wojtkiewicz GR, et al. Vascular and neurogenic rejuvenation
of the aging mouse brain by young systemic factors. Science
27. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R,
et al. Restoring systemic GDF11 levels reverses age-
related dysfunction in mouse skeletal muscle. Science
28. Willcox BJ, He Q, Chen R, Yano K, Masaki KH, Grove JS, et
al. Midlife risk factors and healthy sur vival in men. JAMA
29. Cooper R, Strand BH, Hardy R, Patel KV, Kuh D. Physical
capability in mid-life and survival over 13 years of follow-up:
British birth cohort study. BMJ 2014;348:g2219.
30. Dunlop DD, Song J, Semanik PA, Sharma L, Bathon JM, Eaton
CB, et al. Relation of physical activity time to incident disability
in community dwelling adults with or at risk of knee arthritis:
prospective cohort study. BMJ 2014;348:g2472.
31. Badley E. Inactivity, disability, and death are all interlinked. BMJ
32. Lifestyle change only way to live longer, says Menzies Research
Institute director Thomas Mar wick. The Mercury Apr 27, 2014.
References from Aged Care article on page 33.
www.psa.org.au » firstname.lastname@example.org » 02 9431 1100
advanced clinical education
Designed for pharmacists who want more in depth clinical knowledge
Wednesday, 30 July 2014
Kirribilli Club, 11 Harbourview Crescent, lavender Bay nsW
‘ The contents of the two Webster packs
were consumed by the patient for a
total of nine days, by which time the
patient had developed mouth ulceration
which prevented the patient from eating
properly and led to a hospital admission,
where the packing error was detected
by admitting hospital staff.
‘ The patient’s condition deteriorated
rapidly and the patient died some days
later in hospital. The death was referred
to the Coroner’s Office. The Coroner
subsequently found that the cause of
death was immune system compromise
caused by the toxic effects of
methotrexate dispensed and incorrectly
packed by the pharmacists as daily
instead of once weekly doses’.
The Board’s Notifications Committee
found that the pharmacists’ professional
performance was unsatisfactory, and
referred the matters for hearing by a
Professional Performance Standards
Links Archive Australian Pharmacist June 2014 Australian Pharmacist August 2014 Navigation Previous Page Next Page